Basel Medical Group Ltd (BMGL:NASDAQ) closed at $4.45 on October 26, 2026, up 0.22% on the day. The stock trades 77.5% below its 52-week high of $19.80 and 73.8% above its 52-week low of $2.56. Basel Medical Group Ltd is part of the Health Care sector.
In 251 trading sessions since October 23, 2025, BMGL closed higher on 105 days (42%). Its best day was September 14, 2026 (+55.90%) and its worst was June 4, 2026 (-26.07%). The stock moved 10% or more in a single session 30 times. It opened at least 5% above the previous day's high 2 times.
Basel Medical aims to be a one-stop integrated healthcare provider for all musculoskeletal-related medical care, including post-surgery rehabilitation services such as physiotherapy as well as other ancillary services such as pain management. We operate our two clinics at Gleneagles Medical Centre in Singapore and currently have five medical practitioners practicing with Basel Medical, comprising four orthopedic specialists and one neurosurgery specialist. The services provided by our clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine and neurological conditions and our clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services, while more complex surgical procedures are performed at operating theaters of other hospitals with such facilities.
Find more stocks like BMGL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.